Apomorphine and Parkinson's disease. a major therapeutical progress
Pollak, P.; Gervason, C.L.; Deffond, D.; Perret, J.E.
La Revue du Praticien 42(5): 591-593
1992
ISSN/ISBN: 0035-2640 PMID: 1604186 Document Number: 395860
Document emailed within 1 workday
Related Documents
Giménez-Roldán, S.; García- Muñozguren, S. 2002: Use of apomorphine in Parkinson s disease Revista de Neurologia 35(7): 668-6742005: Apomorphine (Apokyn) for advanced Parkinson's Disease Medical Letter on Drugs and Therapeutics 47(1200): 7-8
Castaigne, P.; Laplane, D.; Dordain, G. 1971: Clinical experimentation with apomorphine in Parkinson's disease Research Communications in Chemical Pathology and Pharmacology 2(2): 154-158
Montastruc, J.L.; Rascol, O.; Senard, J.M.; Houin, G.; Rascol, A. 1995: Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? Journal of Neural Transmission. Supplementum 45: 157-161
Albani, C.; Zangger, I.; Fischer, G. 1992: Subcutaneous apomorphine infusion in the treatment of Parkinson disease Schweizerische Rundschau für Medizin Praxis 81(35): 1011-1015
Pollak, P.; Champay, A.S.; Gaio, J.M.; Hommel, M.; Benabid, A.L.; Perret, J. 1990: Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease Revue Neurologique (Paris) 146(2): 116-122
Jansen, E.N.; van Laar, T. 1990: 'New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine Nederlands Tijdschrift Voor Geneeskunde 134(18): 889-891
Merello, M.; Leiguarda, R. 1995: Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine Medicina 55(1): 5-10
Maggio, R.; Barbier, P.; Corsini, G.U. 1995: Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response Journal of Neural Transmission. Supplementum 45: 133-136
Siemers, E. 1992: Recent progress in the treatment of Parkinson's disease Comprehensive Therapy 18(9): 20-24
Jankovic, J. 2001: Parkinson's disease. a half century of progress Neurology 57(10 Suppl 3: S1-S3
Narabayashi, H. 1990: Recent progress in treatment of Parkinson's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 48(12): 2943-2950
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Indo, T.; Takahashi, A. 1987: Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years Rinsho Shinkeigaku 27(11): 1419-1422
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Laws, J. 2010: Major GHS Progress this year Occupational Health and Safety 79(10): 4
Nagy, G.; Prónay, G.; Ujszászy, L. 1985: Therapeutical experiments in ulcerative colitis and Crohn's disease Acta Medica Hungarica 42(3-4): 163-174
Sabetay, C.; Ciobanu, O.; Zavate, A.; Ciucă, M.; Malos, A.; Marin-Diu, B. 2010: Clinical and therapeutical considerations regarding the diagnosis and treatment in meconial disease Chirurgia 105(1): 67-70